Pro-BNP Peptide Levels Correlate With Blood Count Changes in Heart Failure Patients
Heart failure patients had significantly higher Pro-BNP levels and distinct blood count abnormalities compared to controls, supporting the combined use of natriuretic peptide and CBC parameters for heart failure assessment.
Quick Facts
What This Study Found
Heart failure patients had 2.4× higher Pro-BNP (2,500 vs 1,053 pg/mL) with significant associations to RDW, MCV, and platelet parameters, supporting combined biomarker approaches for HF diagnosis.
Key Numbers
89 participants total; 49 heart failure patients; 40 healthy controls.
How They Did This
Case-control study of 89 participants (42 HF patients, 47 controls) comparing Pro-BNP levels alongside comprehensive CBC parameters with statistical analyses of associations.
Why This Research Matters
Heart failure diagnosis often relies on expensive specialized tests. Discovering that common, inexpensive blood count parameters correlate with Pro-BNP could make heart failure screening more accessible, especially in resource-limited settings.
The Bigger Picture
Natriuretic peptides like Pro-BNP are well-established heart failure biomarkers, but their relationship with routine blood parameters is underexplored. This integrated approach could lead to more comprehensive, accessible diagnostic panels for heart failure.
What This Study Doesn't Tell Us
Small sample size (89 total); case-control design cannot establish causality; single-center study; Pro-BNP cutoff values not defined for this population; potential confounding from medications and comorbidities not fully controlled.
Questions This Raises
- ?Can a combined Pro-BNP + CBC scoring system improve heart failure screening accuracy?
- ?Which CBC parameters are most predictive of heart failure severity independently of Pro-BNP?
- ?Would these findings replicate in larger, more diverse populations?
Trust & Context
- Key Stat:
- 2,500 vs 1,053 pg/mL Pro-BNP levels in heart failure patients vs healthy controls
- Evidence Grade:
- Preliminary evidence from a small case-control study. Confirms known Pro-BNP utility while adding novel associations with CBC parameters.
- Study Age:
- Published in 2024, contributing to ongoing efforts to optimize heart failure biomarker panels.
- Original Title:
- Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case-control study.
- Published In:
- Health science reports, 7(9), e70083 (2024)
- Authors:
- Torfi, Ekhlas, Bahreiny, Seyed S, Saki, Najmaldin, Khademi, Reyhane, Sarbazjoda, Ehsan, Nezhad, Inas A, Aghaei, Mojtaba
- Database ID:
- RPEP-09397
Evidence Hierarchy
Frequently Asked Questions
What does Pro-BNP tell you about heart failure?
Pro-BNP is a hormone fragment released when the heart is under stress. Higher levels indicate worse heart function — in this study, heart failure patients had 2.4 times higher levels than healthy people.
Can a regular blood test help diagnose heart failure?
This study suggests yes — certain routine blood count changes (in red cell size, distribution width, and platelets) were significantly different in heart failure patients and correlated with Pro-BNP levels, potentially adding diagnostic value to standard blood work.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09397APA
Torfi, Ekhlas; Bahreiny, Seyed S; Saki, Najmaldin; Khademi, Reyhane; Sarbazjoda, Ehsan; Nezhad, Inas A; Aghaei, Mojtaba. (2024). Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case-control study.. Health science reports, 7(9), e70083. https://doi.org/10.1002/hsr2.70083
MLA
Torfi, Ekhlas, et al. "Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case-control study.." Health science reports, 2024. https://doi.org/10.1002/hsr2.70083
RethinkPeptides
RethinkPeptides Research Database. "Evaluation of Pro-BNP biomarker in heart failure patients an..." RPEP-09397. Retrieved from https://rethinkpeptides.com/research/torfi-2024-evaluation-of-probnp-biomarker
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.